Regulators And Vertical Mergers: The Case Of The Cancer-Detection Companies Seeking To Re-Merge Cancer-detection companies Illumina and its former start-up, Grail, say they can save lives and reduce costs through a vertical re-merger. However, regulators on both sides of the Atlantic - the U.S. Federal Trade Commission and the European Commission (EC) - disagree, opposing the merger.